The angiogenins: An emerging family of ribonuclease related proteins with diverse cellular functions

Angiogenesis

Volumn 3, Issue 3, 1999, Pages 189-199

  Adams, Susan A ^a   Subramanian, Vasanta ^a  

^a University of Bath   (United Kingdom)

Author keywords

Acute phase reaction; Angiogenesis; Angiogenin; Neoplasia; Polymorphonuclear leukocyte; Ribonuclease

Indexed keywords

VERTEBRATA;

EID: 0001494044     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009015512200     Document Type: Review

References (109)

1. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol 1995; 6: 230-47.
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7.
3. Folkman J, Cotran RS. Relation of vascular proliferation to tumour growth. Int Rev Exp Path 1976; 16: 207-48.
4. Folkman J. Tumour angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1185-6.
5. Blood CH, Zetter BR. Tumour interaction with the vasculature: Angiogenesis and tumour metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
6. Pepper MS, Vassalli JD, Montesano R, Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987; 105: 2535-41.
7. Moscatelli D, Rifkin DB. Membrane and matrix localisation of proteinases - a common theme in tumour cell invasion and angiogenesis. Biochim Biophys Acta 1988; 948: 67-85.
8. Odekon LE, Sato Y, Rifkin DB. Urokinase-type plasminogen activator mediates basic fibroblast growth factor induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 1992; 150: 258-63.
9. Thomas KA, Gimeneg-Gallego G. Fibroblast growth factors: Broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci USA 1986; 11: 81-4.
10. Leung DW, Cachiones G, Kuangiogenin WJ et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-12.
11. Klagsbrun N, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217-39.
12. Haraguchi M, Miyadera K, Uemura K et al. Angiogenic activity of enzymes. Nature 1994; 368: 198.
13. Fett JW, Strydom DJ, Lobb RR et al. Isolation and characterization of Angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24: 5480-6.
14. Strydom DJ, Fett JW, Lobb RR, et al. Amino acid sequence of tumour derived Angiogenin. Biochemistry 1985; 24: 5486-94.
15. Kurachi K, Davie EW, Strydom DJ, Vallee BL. Sequence of the cDNA and gene for Angiogenin, a human angiogenesis factor. Biochemistry 1985; 24: 5494-9.
16. Knighton D, Ausprunk D, Tapper D et al. Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 1977; 35: 347-56.
17. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976; 263: 797-800.
18. Shapiro R, Strydom DJ, Olson KA et al. Isolation of Angiogenin from natural human plasma. Biochemistry 1987; 26: 5141-6.
19. D'Alessio G, Riordan JF. In D'Alessio G, Riordan JF (eds): Ribonucleases: Structure and Function. New York: Academic Press 1997.
20. Sorrentino S, Libonati M. Structure function relationships in human ribonucleases: Main distinctive features of the major RNase types. FEBS Lett 1997; 404: 1-5.
21. Beintema JJ, Schuller C, Irie M et al. Molecular evolution of the ribonuclease superfamily. Prog Biophys Mol Biol 1988; 51: 165-92.
22. Ackerman SJ. In Makino S, Fukada T (eds): Eosinophils: Biological and Clinical Aspects. Boca Raton, Florida: CRC Press 1993.
23. Seno M, Futami J, Tsushuma Y et al. Molecular cloning and expression of human ribonuclease-4 cDNA. Biochem Biophys Acta 1995; 1261: 424-6.
24. Rosenberg HF, Dyer KD. Human ribonuclease-4 (Rnase-4)-coding sequence, chromosomal localization and identification of 2 distinct transcripts in human somatic tissues. Nucleic Acids Res 1995; 23: 4240-95.
25. Rosenberg HF, Dyer KD. Molecular cloning and characterization of a novel human ribonuclease (Rnase k6): Increasing diversity in the enlarging ribonuclease gene family. Nucleic Acids Res 1996; 24: 3507-13.
26. Batten D, Dyer KD, Damachowske JB, Rosenberg HF. Molecular cloning of four novel murine ribonuclease genes: Unusual expansion within the ribonuclease A gene family. Nucleic Acids Res 1997; 25: 4235-9.
27. Larson KA, Olson EV, Madden BJ et al. Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci USA 1996; 93: 12370-5.
28. Bond MD, Strydom DJ, Vallee BL. Characterization and sequencing of rabbit, pig and mouse Angiogenin. Discernment of functionally important residues and regions. Biochim Biophys Acta 1993; 1162: 177-86.
29. Vallee BL, Riordan JF. Organogenesis and Angiogenin. Cell Mol Life Sci 1997; 53: 803-15.
30. Harper JW, Vallee BL. A covalent Angiogenin ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry 1989; 28: 1875-84.
31. Acharya KR, Subramanian V, Shapiro R et al. Crystallization and preliminary X-ray analysis of human Angiogenin. J Mol Biol 1992; 228: 1269-70.
32. Acharya KR, Shapiro R, Allen SC et al. Crystal structure of human Angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc Natl Acad Sci USA 1994; 91: 2915-9.
33. Acharya KR, Leonidas DD, Papageorgiou AC et al. Structural studies on Angiogenin, a protein implicated in neovascularization during tumour growth. In Maragoudakis ME (ed): Angiogenesis: Models, Modulators and Clinical Applications. New York: Plenum Press 1998; 165-78.
34. Russo N, Shapiro R, Acharya KR. Role of glutamine in the ribonucleolytic activity of human Angiogenin. Proc Natl Acad Sci USA 1994; 91: 2920-4.
35. Hallahan TW, Shapiro R, Vallee BL. Dual site mode for the angiogenic activity of Angiogenin. Proc Natl Acad Sci USA 1991; 88: 2222-6.
36. Hallahan TW, Shapiro R, Strydom DJ, Vallee BL. Importance of Asparagine-61 and Asparagine-109 to the angiogenic activity of human Angiogenin. Biochemistry 1992; 31: 8022-9.
37. Acharya KR, Shapiro R, Riordan JF, Vallee BL. Crystal structure of bovine angiogenin at 1.5 Å resolution. Proc Natl Acad Sci USA 1995; 92: 2949-53.
38. Maes P, Damart D, Rommens C et al. The complete amino acid sequence of bovine milk Angiogenin. FEBS Lett 1988; 241: 41-5.
39. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human Angiogenin. Biochemistry 1986; 25: 3527-32.
40. St Clair DK, Rybak SM, Riordan JF, Vallee BL. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes. Biochemistry 1988; 27: 7263-8.
41. Saxena SK, Rybak S, Davey RT et al. Angiogenin is a cytotoxic tRNA-specific ribonuclease in the RNase A superfamily. J Biol Chem 1992; 30: 21982-6.
42. Shapiro R, Vallee BL. Site directed mutagenesis of histidine-13 and histidine-114 of human Angiogenin. Alanine derivatives inhibit Angiogenin-induced angiogenesis. Biochemistry 1989; 28: 7401-8.
43. Shapiro R, Fox EA, Riordan JF. Role of lysines in human Angiogenin: Chemical modification and site-directed mutagenesis. Biochemistry 1989; 28: 1726-32.
44. Curran TP, Shapiro R, Riordan JF. Alteration of the enzymatic specificity of human Angiogenin by site-directed mutagenesis. Biochemistry 1993; 32: 2307-13.
45. Rybak SM, Vallee BL. Base cleavage specificity of Angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNAs. Biochemistry 1988; 27: 2288-94.
46. Shapiro R, Weremowicz S, Riordan JF, Vallee BL. Ribonucleolytic activity of Angiogenin - essential histidine, lysine and arginine residues. Proc Natl Acad Sci USA 1987; 84: 8783-7.
47. Hu GF, Riordan JF, Vallee BL. A putative Angiogenin receptor in Angiogenin-responsive human endothelial cells. Proc Natl Acad Sci USA 1997; 94: 2204-9.
48. Hu GF, Strydom DJ, Fett JW et al. Actin is a binding protein for Angiogenin. Proc Natl Acad Sci USA 1993; 90: 1217-21.
49. Olson KA, Fett JW, French TC et al. Angiogenin antagonists prevent tumour growth in vivo. Proc Natl Acad Sci USA 1995; 92: 442-6.
50. Kinoshita N, Minshull J, Kirschner MW. The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell 1995; 83: 621-30.
51. Badet J, Soncin G, Guitton JD et al. Specific binding of Angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci USA 1989; 86: 8427-31.
52. Soncin F, Guitton JD, Cartwright T, Badet J. Interaction of human Angiogenin with copper modulates Angiogenin binding to endothelial cells. Biochem and Biophys Res Commun 1997; 236: 604-10.
53. Chamoux M, Dehouck MP, Fruchart JC et al. Characterization of Angiogenin receptors on bovine brain endothelial cells. Biochem Biophys Res Commun 1991; 176: 833-9.
54. Moroianu J, Riordan JF. Nuclear translocation of Angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 1994; 91: 1677-81.
55. Li R, Riordan JF, Hu GF. Nuclear translocation of human Angiogenin in cultured human umbilical artery endothelial cells is microtubule and lysosome independent. Biochem Biophys Res Commun 1997; 238: 305-12.
56. Lobie PE, Mertani H, Morel G et al. Receptor mediated nuclear translocation of growth hormone. J Biol Chem 1994; 269: 21330-9.
57. Moroianu J, Riordan JF. Identification of the nucleolar targeting signal of human Angiogenin. Biochem Biophys Res Commun 1994; 203: 1765-72.
58. Lee WW, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-41.
59. Bicknell R, Vallee BL. Angiogenin activates endothelial cell phospholipase C. Proc Natl Acad Sci USA 1988; 85: 5961-5.
60. 2. Proc Natl Acad Sci USA 1989; 86: 1573-7.
61. Shapiro R, Vallee BL. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of Angiogenin. Proc Natl Acad Sci USA 1987; 24: 2238-41.
62. Shapiro R, Vallee BL. Interaction of human placental ribonuclease with placental ribonuclease I inhibitor. Biochemistry 1991; 30: 2246-55.
63. Lee FS, Shapiro RS, Vallee BL. Tight-binding inhibition of Angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry 1989; 28: 225-30.
64. Lee FS, Fox EA, Zhou HM et al. Primary structure of human placental ribonuclease inhibitor. Biochemistry 1988; 27: 8545-53.
65. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993; 366: 751-6.
66. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
67. Trey JE, Kusher I. The acute phase response and the haematopoeitic system: the role of cytokines. Crit Rev Oncol Hematol 1994; 15: 74-80.
68. Olson K, Verseilis SJ, Fett JW. Angiogenin is regulated in vivo as an acute phase protein. Biochem and Biophys Res Commun 1998; 242: 480-3.
69. Hu GF, Riordan JF. Angiogenin enhances actin acceleration of plasminogen activation. Biochem Biophys Res Commun 1993; 197: 682-7.
70. Hu GF, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci USA 1994; 91: 12096-100.
71. Jimi S, Ito K, Kohno K et al. Modulation by bovine Angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem Biophys Res Commun 1995; 211: 476-83.
72. Sillix DH, Francis J, Mahajan S, Briggs W. Impaired granulocyte phagocytosis and bacteriocidal activity in nephrotic syndrome. Kidney Int 1983; 23: 93-6.
73. Tolkoff-Rubin NE, Rubin RH. Uremia and host defenses. N Engl J Med 1990; 322: 770-2.
74. Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192-201.
75. Ritchey EE, Wallin JD, Shah SV. Chemi-luminescence and superoxide anion production by leukocytes from chronic haemodialysis patients. Kidney Int 1981; 19: 349-58.
76. Haag-Weber M, Horl WH. Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia? Nephrol Dial Transplant 1996; 11: 98-100.
77. Mansell MA, Grimes AJ, Jones NF. Leukocyte ATP and renal failiure. Clin Sci 1981; 61: 43-6.
78. Tschesche H, Kopp C, Horl WH, Hempelmann U. Inhibition of degranulation of polymorphonuclear leukocytes by Angiogenin and its tryptic fragment. J Biol Chem 1994; 48: 30274-80.
79. Matousek J, Soucek J, Riha J et al. Immunosuppressive activity of Angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Comp Biochem Physiol. Part 2 Biochem Mol Biol 1995; 63: 249-56.
80. Hu GF. Limited proteolysis of Angiogenin by elastase is regulated by plasminogen. J Protein Chem 1997; 16: 669-79.
81. O'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
82. Weiner HL, Weiner LH, Swain JL. Tissue distribution and developmental expression of the messenger RNA encoding Angiogenin. Science 1987; 237: 280-2.
83. Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc Natl Acad Sci USA 1992; 89: 2232-6.
84. Soncin F, Shapiro R, Fett JW. A cell-surface proteoglycan mediates human adenocarcinoma HT-29 cell adhesion to human Angiogenin. J Biol Chem 1994; 269: 8999-9005.
85. Soncin F, Strydom D, Shapiro R. Interaction of heparin with human Angiogenin. J Biol Chem 1997; 15: 9818-24.
86. Li D, Bell J, Brown A et al. The observation of Angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas and hepatocellular carcinomas. J Pathol 1994; 172: 171-5.
87. Chopra V, Dinh TV, Hannigan EV. Serum levels of interleukins, growth factors and Angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol 1997; 123: 167-72.
88. Chopra V, Dinh TV, Hannigan EV. Circulating serum levels of cytokines and Angiogenic factors in patients with cervical cancer. Cancer Invest 1998; 16: 152-9.
89. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased Angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 1996; 56: 2703-6.
90. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB, Klein CE. Hypoxia-induced up-regulation of Angiogenin in human malignant melanoma. Cancer Res 1999; 59: 1578-83.
91. Olson KA, French TC, Vallee BL, Fett JW. A monoclonal antibody to human Angiogenin suppresses tumour growth in athymic mice. Cancer Res 1994; 54: 4576-9.
92. Olson KA, Fett J. Prostatic carcinoma therapy with Angiogenin antagonists. Proc Ame Assoc Cancer Res 1996; 37: 57.
93. Olson KA, Fett JW. Inhibition of tumour growth and metastasis by Angiogenin antisense therapy. Proc Am Assoc Cancer Res 1998; 39: 98.
94. Burgmann H, Hollenstein U, Maca T et al. Increased serum laminin and Angiogenin concentrations in patients with peripheral arterial occlusive disease. J Clin Pathol 1996; 49: 508-10.
95. Hosaka S, Shah MR, Barquin N et al. Expression of basic fibroblast growth factor and Angiogenin in arthritis. Pathobiol 1995; 63: 249-56.
96. Ozaki H, Hayashi H, Oshima K. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy. Opthalmic Res 1996; 28: 356-60.
97. Gho YS, Chae CD. Anti angiogenic activity of the peptides complementary to the receptor binding site of Angiogenin. J Biol Chem 1997; 272: 24294-9.
98. Kolben M, Blaser J, Ulm K et al. Angiogenin plasma levels during pregnancy. Am J Obstet Gynaecol 1997; 176: 37-41.
99. Malamitsi-Puchner A, Sarandakou A, Giannaki G et al. Changes of Angiogenin serum concentrations in the perinatal period. Pediatr Res 1997; 41: 909-11.
100. Spong CY, Ghidini A, Walker CN et al. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischaemia. Am J Obstet Gynaecol 1997; 177: 1085-7.
101. Strydom DJ, Bond MD, Vallee BL. An angiogenic protein from bovine serum and milk-purification and primary structure of Angiogenin-2. Eur J Biochem 1997; 247: 535-44.
102. Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 1997; 17: 1503-12.
103. Kamps MP, Baltimore DL. E2a-Pbx1, the t(1;19) translocation protein of human pre-B cell ALL, causes acute myeloblastic leukaemia in mice. Mol Cell Biol 1993; 13: 351-7.
104. Dedera DA, Waller EK, Lebrum DP. Chimeric homeobox gene E2a-Pbx1 induces proliferation, apoptosis and malignant lymphomas in transgenic mice. Cell 1993; 74: 833-43.
105. Brown WE, Nobile V, Subramanian V, Shapiro R. The mouse Angiogenin gene family: structures of an Angiogenin related protein gene and two pseudogenes. Genomics 1995; 29: 200-6.
106. Nobile V, Vallee BL, Shapiro R. Characterization of mouse Angiogenin-related protein: implications for functional studies on Angiogenin. Proc Natl Acad Sci USA 1996; 93: 4331-5.
107. Adams MD, Kierlavage AR, Fleischmann RD et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995; 377(6547 Suppl): 3-174.
108. Rybak SM, Fett JW, Yao QZ, Vallee BL. Angiogenin mRNA in human tumour and normal cells. Biochem Biophys Res Com 1987; 146: 1240-3.
109. Chang SI, Jeong GB, Park SH et al. Detection, quantitation, and localization of bovine Angiogenin by immunological assays. Biochem Biophys Res Com 1997; 232: 323-7.